Press release
Pulmonary Arterial Hypertension Market Increasing Demand By Novartis AG (Switzerland), United Therapeutics Corporation (US), Arena Pharmaceuticals, Inc. (US), Asklepion Pharmaceuticals, LLC.(US), AstraZeneca (UK)
Pulmonary Arterial Hypertension Market
The major competitors currently working in the pulmonary arterial hypertension market are Actelion Pharmaceuticals Ltd (Switzerland), DAIICHI SANKYO COMPANY, LIMITED. (Japan), GlaxoSmithKline plc. (UK), Novartis AG (Switzerland), United Therapeutics Corporation (US), Arena Pharmaceuticals, Inc. (US), Asklepion Pharmaceuticals, LLC.(US), AstraZeneca (UK), Bayer AG (Germany), Berlin Cures GmbH (Germany), DEKA Research & Development Corp. (US), Dong- A ST (South Korea), Eiger BioPharmaceuticals (US), Gilead Sciences, Inc. (US), Lung Biotechnology PBC (US), Merck KGaA (Germany), Northern Therapeutics, Inc. (Canada), Pfizer Inc. (US), PhaseBio Pharmaceuticals, Inc. (US), Radikal Therapeutics (US), Reata Pharmaceuticals, Inc. (US), and North Carolina Biotechnology Center (US) few among others.
Get Sample Report at https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-pulmonary-arterial-hypertension-pah-market
Market Definition: Global Pulmonary Arterial Hypertension Market
Pulmonary hypertension is a condition in which the blood pressure of the lung vasculature rises above 15-20mmHg due to multiple reasons including rigidness of pulmonary artery that carries blood to lungs from right ventricle. It causes shortness of breath, fainting and even leads to cardiac arrest.
According to various sources including WHO and CDC, around 115,000- 231,000 people are affected by pulmonary hypertension, that is about 15-30 patients per million of the population, almost more than half of these cases could have been avoided with the availability of proper medical treatment for healthcare procedures. This significant number is expected to act as a driver to the market growth.
Market Drivers
Increase in the prevalence rate of the disease.
Rise in healthcare spending and huge pipeline molecules will drive the growth of the market.
Change in the lifestyle of population that includes tobacco consumption, low air quality index in urban areas.
Market Restraints
Lack of awareness in people.
Unsuccessful clinical trials will restrain the growth of the market.
Get TOC at https://www.databridgemarketresearch.com/toc/?dbmr=global-pulmonary-arterial-hypertension-pah-market
Segmentation: Global Pulmonary Arterial Hypertension Market
By Drug Class
Endothelin Receptor Antagonists (ERAs)
Vasodilators
Phosphodiesterase-5 (PDE-5) inhibitors
Soluble Guanylate Cyclase (sGC) Stimulators
Calcium Channel Blockers (CCBs)
Prostacyclin and prostacyclin analogs
Others (anticoagulants, diuretics, and cardiac glycosides)
By Route of Administration
Inhalation
Injectable
Oral administration
By End-users
Hospitals
Clinics
Others
By Geography
North America
South America
Europe
Asia-Pacific
Middle East & Africa
Key Developments in the Market:
On 22nd March, 2016, Actelion Ltd announced that, Therapeutic Goods Administration (TGA) of Australia and the New Zealand Medicines and Medical Devices Safety Authority (Medsafe) have granted approval for Uptravi (selexipag) for the treatment of pulmonary arterial hypertension.
On 15th November 2018, Arena Pharmaceuticals and United Therapeutics entered into an exclusive license agreement related to ralinepag, which is currently being evaluated for the treatment of PAH. Under the agreement, United Therapeutics got an exclusive and irrevocable license to develop, manufacture and commercialize ralinepag in any formulation for pulmonary hypertension.
Competitive Analysis:
Global pulmonary arterial hypertension market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of pulmonary arterial hypertension market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Reasons to Purchase this Report
Current and future of global pulmonary arterial hypertension market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report:
All segmentation provided above in this report is represented at country level
All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
Inquiry Before Buying @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-pulmonary-arterial-hypertension-pah-market
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pulmonary Arterial Hypertension Market Increasing Demand By Novartis AG (Switzerland), United Therapeutics Corporation (US), Arena Pharmaceuticals, Inc. (US), Asklepion Pharmaceuticals, LLC.(US), AstraZeneca (UK) here
News-ID: 2166106 • Views: …
More Releases from Data Bridge Market Research
Water Treatment System Market: Sustaining the Future of Clean Water
Introduction
Understanding Water Treatment Systems
Water treatment systems are designed to purify and disinfect water for various uses-drinking, industrial processes, irrigation, and wastewater reuse. These systems eliminate contaminants such as bacteria, viruses, heavy metals, chemicals, and particulates, making water safe and sustainable for consumption and use.
Importance in Global Sustainability
Clean water is essential to life and industrial progress. With growing water demand and pollution, water treatment systems are now critical infrastructure across the…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032.
With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal…
More Releases for Pulmonary
Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers…
Global Pulmonary Embolism Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Pulmonary Embolism Market is exhibited at USD 1.59 billion in 2023 and is projected to surpass USD 3.15 billion in 2028, anticipated to grow at a CAGR of 8.4% from 2023 to 2028.
The rapid increase in the prevalence of cancer, increasing investment for healthcare infrastructure and rising research and development activities, high disposable income, rising demand…
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027.
Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion.
Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC…
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of…
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs
Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated…
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market.
This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments…
